Colossal raised $200M in a Series C funding led by TWG Global to support its scientific breakthroughs on the path to de-extinction.

Jan 15, 2025•11 months ago

Amount Raised

$200 Million

AustinBiotechnology

Investors

Twg Global

Description

Colossal has secured $200 million in Series C funding from TWG Global. This investment will aid the company in its numerous scientific advancements aimed at de-extinction.

Company Information

Company

Colossal Biosciences

Location

Austin, Texas, United States

About

Colossal was founded by emerging technology and software entrepreneur Ben Lamm and world-renowned geneticist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Colossal is accepting humanity's duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

Related People

3 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends